Overview of Dr. Haggiagi
Neurology and Neuro-Oncology
Office
710 West 168th Street
New York, NY 10032
Education & Training
University of Tripoli School of MedicineClass of 2006
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2021 - 2025
NY State Medical License 2015 - 2025
CT State Medical License 2021 - 2022- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- ColumbiaDoctors Team Building Award ColumbiaDoctors, 2018
- Too Abstract Award Soviet for Neuro-oncology, 2017
Clinical Trials
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) Start of enrollment: 2023 Jan 23
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 7 citationsONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, Dolly Aguilera, Joshua E Allen
Journal of Clinical Oncology. 2024-05-01 - 7 citationsAxicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience.Carlen A Yuen, Jing-Mei Hsu, Koen Van Besien, Ran Reshef, Fabio M Iwamoto
Journal of Immunotherapy. 2022-06-01 - 6 citationsNewly Diagnosed Glioblastoma in Elderly Patients.Carlen A Yuen, Marissa Barbaro, Aya Haggiagi
Current Oncology Reports. 2022-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
